Tools · Private company
Canfield Scientific Inc.
Track this companyFree. Adds Canfield Scientific Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials74 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials7
- Using an Artificial Intelligence (AI) Tool for Melanoma DiagnosisPHASE3 · RECRUITING · started Oct 15, 2026ClinicalTrials.gov NCT07890415 · fetched Nov 12, 2026
- Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)PHASE3 · RECRUITING · started Jun 15, 2026ClinicalTrials.gov NCT07637734 · fetched Nov 12, 2026
- Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)PHASE3 · RECRUITING · started Mar 11, 2026ClinicalTrials.gov NCT07457918 · fetched Nov 12, 2026
- Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)PHASE3 · ACTIVE_NOT_RECRUITING · started Dec 17, 2025ClinicalTrials.gov NCT07246590 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2)PHASE3 · COMPLETED · started Aug 17, 2023ClinicalTrials.gov NCT05914805 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair LossPHASE3 · COMPLETED · started Jun 21, 2023ClinicalTrials.gov NCT05910450 · fetched Nov 12, 2026
- Open-Label Proof of Concept Study of VP-315 in Basal Cell CarcinomaPHASE2 · COMPLETED · started Feb 1, 2022ClinicalTrials.gov NCT05188729 · fetched Nov 12, 2026